<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05106803</url>
  </required_header>
  <id_info>
    <org_study_id>Antibiotic profile in Jordan</org_study_id>
    <nct_id>NCT05106803</nct_id>
  </id_info>
  <brief_title>Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan</brief_title>
  <official_title>Antibiotic Profile of Pathogenic Bacteria Isolated From Postsurgical Site Infections in Public Hospitals in Northern Jordan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yarmouk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yarmouk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of the study was to identify the various pathogens associated with surgical site&#xD;
      infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Surgical site infections are hospital-acquired, vary from one hospital to&#xD;
      another, and can cause significant postoperative morbidity, mortality, and prolonged hospital&#xD;
      stay.&#xD;
&#xD;
      Aim: The main aim of the study was to identify the various pathogens associated with surgical&#xD;
      site infections and their antibiotic susceptibility in a governmental hospital in northern&#xD;
      Jordan.&#xD;
&#xD;
      Methods: Postsurgical wound samples were collected and processed in a microbiology laboratory&#xD;
      using standard microbiological techniques. Antibiotic susceptibility tests were performed&#xD;
      using 13 antibiotics covering the gram-positive and gram-negative bacteria using the disc&#xD;
      diffusion test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Actual">October 1, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive culture</measure>
    <time_frame>August 2019 to October 2019</time_frame>
    <description>Positive swab culture from the wound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gram stain and type of Bacteria</measure>
    <time_frame>August 2019 to October 2019</time_frame>
    <description>Gram stain and type of Bacteria grown in culture media</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic Susceptibility</measure>
    <time_frame>August 2019 to October 2019</time_frame>
    <description>Antibiotic Susceptibility to the isolated organisms</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Bacterial Infections</condition>
  <condition>Antibiotic Resistant Infection</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Wound infection</arm_group_label>
    <description>Patients with surgical site infection as diagnosed by the attending physician</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ciprofloxacin</intervention_name>
    <description>Antibiotics used in vitro n the study</description>
    <arm_group_label>Wound infection</arm_group_label>
    <other_name>trimethoprim-sulfamethoxazole</other_name>
    <other_name>norfloxacin</other_name>
    <other_name>erythromycin</other_name>
    <other_name>chloramphenicol</other_name>
    <other_name>gentamicin</other_name>
    <other_name>tetracycline</other_name>
    <other_name>vancomycin</other_name>
    <other_name>amoxicillin/clavulanic acid</other_name>
    <other_name>cefepime</other_name>
    <other_name>penicillin</other_name>
    <other_name>ampicillin</other_name>
    <other_name>clindamycin</other_name>
    <other_name>oxacillin</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A hospital-based prospective study was carried out in Public-Teaching Hospital in northern&#xD;
        Jordan with a total capacity of 400 beds, All patients meet the criteria of getting&#xD;
        post-operative wound infections in different surgical wards and ICUs.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post-Surgical Wound Infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Raed M Ennab</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yarmouk University</name>
      <address>
        <city>Irbid</city>
        <zip>21163</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 24, 2021</study_first_submitted>
  <study_first_submitted_qc>October 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>October 24, 2021</last_update_submitted>
  <last_update_submitted_qc>October 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yarmouk University</investigator_affiliation>
    <investigator_full_name>Raed M Ennab</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>antimicrobial</keyword>
  <keyword>hospital</keyword>
  <keyword>post-surgical infection</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Tetracycline</mesh_term>
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Cefepime</mesh_term>
    <mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
    <mesh_term>Norfloxacin</mesh_term>
    <mesh_term>Oxacillin</mesh_term>
    <mesh_term>Chloramphenicol</mesh_term>
    <mesh_term>Trimethoprim</mesh_term>
    <mesh_term>Sulfamethoxazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

